Equity
Treasury Stock, Value
Boston Scientific Treasury Stock, Value remained flat by 0.0% to $2.25B in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.25B to $2.25B. Over 5 years (FY 2020 to FY 2025), Treasury Stock, Value shows relatively stable performance with a 0.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalLower is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase indicates active share buyback programs, often used to return capital to shareholders or offset dilution from stock-based compensation.
Detailed definition
The cost of shares that the company has repurchased from the open market and holds in its own treasury. These shares are...
Peer comparison
Common among large-cap medical device firms using buybacks to manage earnings per share.
Metric ID:
equity_treasury_stock_valueHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B | $2.25B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Range$2.25B – $2.25B
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak19+ quarters growth
Treasury Stock, Value at Other Companies
Frequently Asked Questions
- What is Boston Scientific's treasury stock, value?
- Boston Scientific (BSX) reported treasury stock, value of $2.25B in Q1 2026.
- How has Boston Scientific's treasury stock, value changed year-over-year?
- Boston Scientific's treasury stock, value decreased by 0.0% year-over-year, from $2.25B to $2.25B.
- What is the long-term trend for Boston Scientific's treasury stock, value?
- Over 5 years (2020 to 2025), Boston Scientific's treasury stock, value has grown at a 0.0% compound annual growth rate (CAGR), from $2.25B to $2.25B.
- What does treasury stock, value mean?
- The value of shares the company has bought back from the market.